Hypophysen- und Hypothalamushormone

  • Chapter
  • First Online:
Arzneiverordnungs-Report 2020
  • 2965 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, Abou-Setta AM (2011) Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2011(5):CD1750

    Google Scholar 

  • Andrejak M, Tribouilloy C (2013) Drug-induced valvular heart disease: an update. Arch Cardiovasc Dis 106:333–339

    Article  PubMed  Google Scholar 

  • Choi J, Smitz J (2014) Luteinizing hormone and human chorionic gonadotropin: origins of difference. Mol Cell Endocrinol 383:203–213

    Article  CAS  PubMed  Google Scholar 

  • Deutsches IVF-Register (2019) Jahrbuch 2018. J Reproduktionsmed Endokrinol 16:279–315

    Google Scholar 

  • Fleseriu M (2011) Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review. Pituitary 14:184–193

    Article  CAS  PubMed  Google Scholar 

  • van der Lely AJ, Biller BM, Brue T, Buchfelder M, Ghigo E, Gomez R, Hey-Hadavi J, Lundgren F, Rajicic N, Strasburger CJ, Webb SM, Koltowska-Häggström M (2013) Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY. J Clin Endocrinol Metab 97:1589–1597

    Article  Google Scholar 

  • Melmed S (2006) Acromegaly. N Engl J Med 355:2558–2573

    Article  CAS  PubMed  Google Scholar 

  • Melmed S (2019) Pathogenesis and diagnosis of growth hormone deficiency in adults. N Engl J Med 380:2551–2562

    Article  CAS  PubMed  Google Scholar 

  • Mochtar MH, Danhof NA, Ayeleke RO, Van der Veen F, van Wely M (2017) Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles. Cochrane Database Syst Rev 5:CD5070. https://doi.org/10.1002/14651858.CD005070.pub3

    Article  PubMed  Google Scholar 

  • Moore WV, Nguyen HJ, Kletter GB, Miller BS, Rogers D, Ng D, Moore JA, Humphriss E, Cleland JL, Bright GM (2016) A randomized safety and efficacy study of somavaratan (VRS-317), a long-acting rhGH, in pediatric growth hormone deficiency. J Clin Endocrinol Metab 101:1091–1097

    Article  CAS  PubMed  Google Scholar 

  • National Institute for Health and Care Excellence (2010) Human growth hormone (somatropin) for the treatment of growth failure in children. NICE technology appraisal guidance 188. http://www.nice.org.uk/guidance/ta188/resources/guidance-human-growth-hormone-somatropin-for-the-treatment-of-growth-failure-in-children-pdf

  • Pacchiarotti A, Sbracia M, Frega A, Selman H, Rinaldi L, Pacchiarotti A (2010) Urinary hMG (Meropur) versus recombinant FSH plus recombinant LH (Pergoveris) in IVF: a multicenter, prospective, randomized controlled trial. Fertil Steril 94:2467–2469

    Article  CAS  PubMed  Google Scholar 

  • Perales-Puchalt A, Legro RS (2013) Ovulation induction in women with polycystic ovary syndrome. Steroids 78:767–772

    Article  CAS  PubMed  Google Scholar 

  • Weiss NS, Kostova E, Nahuis M, Mol BWJ, van der Veen F, van Wely M (2019) Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Cochrane Database Syst Rev 1:CD10290. https://doi.org/10.1002/14651858.CD010290.pub3

    Article  PubMed  Google Scholar 

  • van Wely M, Kwan I, Burt AL, Thomas J, Vail A, Van der Veen F, Al-Inany HG (2012) Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. A Cochrane review. Hum Reprod Update 18:111

    Article  PubMed  Google Scholar 

  • Youssef MA, Abou-Setta AM, Lam WS (2016) Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles. Cochrane Database Syst Rev 4:CD3719. https://doi.org/10.1002/14651858.CD003719.pub4

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ulrich Schwabe .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Der/die Herausgeber bzw. der/die Autor(en), exklusiv lizenziert durch Springer-Verlag GmbH, DE, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Schwabe, U. (2020). Hypophysen- und Hypothalamushormone. In: Schwabe, U., Ludwig, WD. (eds) Arzneiverordnungs-Report 2020. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-62168-4_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-62168-4_28

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-62167-7

  • Online ISBN: 978-3-662-62168-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Navigation